Premium
Consortium Outlines 3 Solutions to Maximize the Benefit and Affordability of Targeted Cancer Drugs
Publication year - 2018
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.31673
Subject(s) - medicine , citation , medicaid , cancer drugs , cancer , family medicine , health care , law , political science